Literature DB >> 30921308

High level of capture of coronary intervention and associated acute coronary syndromes in the all New Zealand acute coronary syndrome quality improvement cardiac registry and excellent agreement with national administrative datasets (ANZACS-QI 25).

Andrew J Kerr1, Mildred Lee2, Yannan Jiang3, Corina Grey4, Sue Wells4, Michael Williams5, Rod Jackson4, Katrina Poppe4.   

Abstract

BACKGROUND: The All New Zealand Acute Coronary Syndrome Quality Improvement (ANZACS-QI) registry was designed to collect data on all coronary angiograms and percutaneous coronary interventions (PCI) in New Zealand, and all acute coronary syndromes (ACS) associated with these procedures. This study compares the completeness of capture in ANZACS-QI of coronary procedures and ACS admissions with those recorded in the National Hospitalisation Dataset and evaluates data quality by assessing agreement in ACS diagnoses and coronary procedures between datasets.
METHODS: The national dataset, which included all New Zealand public hospital admissions in 2015 (n=962,700 episodes), was anonymously linked with the ANZACS-QI CathPCI (n=14,649 coronary angiogram episodes) and ACS cohorts (n=8,141 episodes) for 2015. Total numbers of coronary angiogram, PCI and ACS admissions were used as denominators and calculated by combining unique episodes from both data sources.
RESULTS: Of all coronary angiogram episodes (n=15,377) and all PCI episodes (n=5,711), 92% were captured in both datasets, 5% in the national dataset only and 3% in ANZACS-QI only. Overall, 95% of coronary angiogram and PCI episodes were captured in ANZACS-QI. Of ACS episodes with associated coronary angiography (n=8,237), 85% were captured. Overall, 54% of all ACS episodes (n=15,167) were captured, including 71% in <70-year-olds. Seventy-five percent of all ST-elevation myocardial infarctions (STEMI) were captured. Ninety percent of ACS diagnoses in ANZACS-QI had a matching diagnosis in the national dataset. There was excellent agreement in recorded gender, date of birth and ethnicity (>99%). Sub-type of ACS was also highly concordant for STEMI and non-STEMI diagnoses (92% and 89% agreement, respectively).
CONCLUSIONS: Consistent with its aim, the ANZACS-QI registry captured almost all New Zealand public hospital coronary angiography and PCI procedures including those associated with an ACS diagnosis. The high level of agreement between the registry and national dataset supports the use of both datasets for ongoing quality improvement reporting and research.

Entities:  

Mesh:

Year:  2019        PMID: 30921308

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  6 in total

1.  Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

Authors:  Lianne Parkin; Sheila Williams; David Barson; Katrina Sharples; Simon Horsburgh; Rod Jackson; Jack Dummer
Journal:  BMJ Open Respir Res       Date:  2021-01

2.  Prehospital identification of ST-segment elevation myocardial infarction and mortality (ANZACS-QI 61).

Authors:  Becky Yi-Wen Liao; Mildred Ai Wei Lee; Bridget Dicker; Verity F Todd; Ralph Stewart; Katrina Poppe; Andrew Kerr
Journal:  Open Heart       Date:  2022-01

3.  Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden study.

Authors:  Peter Lee; A J Kerr; Yannan Jiang; Ella Zomer; Danny Liew
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

4.  The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).

Authors:  Daniel Zl Chan; Ralph Ah Stewart; Andrew J Kerr; Bridget Dicker; Campbell V Kyle; Philip D Adamson; Gerry Devlin; John Edmond; Seif El-Jack; John M Elliott; Nick Fisher; Charmaine Flynn; Mildred Lee; Yi-Wen Becky Liao; Maxine Rhodes; Tony Scott; Tony Smith; Martin K Stiles; Andrew H Swain; Verity F Todd; Mark Wi Webster; Michael Ja Williams; Harvey D White; Jithendra B Somaratne
Journal:  Lancet Reg Health West Pac       Date:  2020-11-20

5.  Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study.

Authors:  Peter Lee; Angela L Brennan; Dion Stub; Diem T Dinh; Jeffrey Lefkovits; Christopher M Reid; Ella Zomer; Danny Liew
Journal:  BMJ Open       Date:  2021-12-07       Impact factor: 2.692

6.  Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population-based nested case-control study.

Authors:  Lianne Parkin; Sheila Williams; Katrina Sharples; David Barson; Simon Horsburgh; Rod Jackson; Billy Wu; Jack Dummer
Journal:  J Intern Med       Date:  2021-07-21       Impact factor: 8.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.